Aniling’s technology solves DNA sequencing critical limitations allowing to boost analysis and get the most out of our DNA, dramatically enhancing quality and integrating genetic and epigenetic information.

Our technology will not only accelerate the discovery of new targets and mechanisms involved in diseases as cancer, diabetes or Alzheimer, but it will also offer a direct-to-user tool to access the genomic and epigenomic information in a broad spectrum of applications related with health and quality of life.